0000 00 00 jointnon-lethal weapons tech

7/29/2019 0000 00 00 JointNon-Lethal Weapons Tech

1/12

J oint Non-Lethal Weapons Program Overview

Non-Lethal Weapons Research & Technology DevelopmentIndustry Day

Col Tracy TafollaDirector, J oint Non-Lethal Weapons Directorate

22 J une 2012

http://jnlwp.defense.govDistribution Statement A:

Approved for public release;Distribution is unlimited

Col Tracy J . TafollaUnited States Marine Corps

Director

J oint Non-Lethal Weapons Directorate

3097 Range Road Telephone: DSN 278 or (703) 784-1977

Quantico, Virginia 22134 FAX: DSN 278 or (703) 784-3178http://jnlwp.defense.gov Classified FAX: DSN 278-9896

[email protected]
http://jnlwp.defense.gov/http://jnlwp.defense.gov/


2/12

Department of Defense (DoD)

Non-Lethal Weapons (NLW) Program

Established in 1996 with the Commandant ofthe Marine Corps as the DoD NLW Executive Agent

The J oint Non-Lethal Weapons Directorate serves as

the Executive Agents day to day management office,

coordinating activities with the Services, Coast Guard,

and other government agencies

The Executive Agent has a research budget dedicated to developing andadvancing the suite of non-lethal weapons available to U.S. forces

The military Services (Army, Air Force, Navy, Marine Corps) are responsiblefor NLW procurement and sustainment

General James F. Amos

Commandant of the U.S.Marine Corps

2Distribution A: Approved for public release; distribution unlimited

Non-lethal effects are part of the Department of Defense portfol io of capabili ties that

enhance the Joint Force Commanders ability to act in a timely manner to detect, deter,

prevent, defeat, or, if necessary, mit igate effects of an attack. General James F. Amos


3/12

DoD NLW Program Management

Structure

J ointS&T

J ointR&D

ServiceS&T

ServiceRDT&E

ServiceProcurement

J oint Non-LethalWeapons Directorate

Chairman, J NLWIntegrated Product Team(DC PP&O)

ServiceO&M

J oint Non-Lethal Weapons Program

DoD Non-LethalWeapons Program

Direct Oversight Coordination

USD(P)Policy Oversight

Service-UniqueNon-Lethal Weapons

Programs

USD(AT&L)Principal Oversight

Mr Kendall

GeneralAmos

DoD NLW ProgramExecutive Agent

CMC

Dr Miller

Col TracyTafolla

LtGen Tryon



4/12

Joint Non-Lethal Weapons

Directorate

DIRECTOR

DEPUTY DIRECTOR

PRINCIPAL DEPUTY

POLICY/& STRATEGY

TECHNOLOGY DIVISION

PRINCIPAL DEPUTY

TECHNOLOGY TRANSITION

AND INTEGRATION

ACQUISITION DIVISION CAPABILITIES &

REQUIREMENTS DIVISION

STRATEGIC COMMS OFF

OPERATIONS DIVISION

JNLWD DESIGNATED AS

JOINTLY MANNED ACTIVITY

18 NOVEMBER 1999

HEALTH EFFECTS

OFFICE

BUSINESS FINANCIALMANAGEMENT OFFICE

STRATEGIC

COMMUNICATION

OFFICE

Distribution A: Approved for public release; distribution unlimited4


5/12

JNLWP Budget

BA-3

~ 11M/yr

BA-4

~ 45M/yr

JNLWP

BA-2

~ 6M/yr

BA-2: Appl ied Research (USN ONR/OSD Oversight)

NL studies and analysis to augment and support current J NLWP areas of interest as well as explore new NLWtechnology opportunities: Includes experimentation and model development. (TRL 2&3)

BA-3: Advanced Technology Development (USN ONR/OSD Oversight )

Next generation NLW concepts and advanced prototype development to support challenging mission needs:Includes laboratory and field testing and model verification and validation. (TRL 4&5)

BA-4: Advanced Component Development and Prototypes (ACD&P) (DC PP&O and ONR Oversight)

Primary source of funds. Supports research and development of J NLWP efforts: includes efforts necessary toevaluate integrated technologies, prototype systems and to expedite technology transition from laboratory to

operational use. (TRL 6&7)



6/12

DoD NLW Definition

Weapons that are explicitly designed and primarily employed so as to

incapacitate personnel or materiel, while minimizing fatalities,permanent injury to personnel, and undesired damage to property and

the environment.

Representative Mission ApplicationsHumanitarian Assistance/Disaster ReliefVehicle/Vessel StoppingClearing Structures/FacilitiesCheck-Point /Convoy Security

Crowd Control

FOB/Facility SecurityMaritime Stability OperatoinsSupport to Civil AuthoritiesDetainee Operations

Counter Piracy

Key Attributes: Incapacitation and Reversibility



7/12

Risk of Significant Injury (RSI)

RSI is a measure of reversibility

Health care capability (HCC) indexes are used as the basis todetermine RSI from NLW.

2

1

0

Limited FirstResponderCapability(LFRC): Self-aid,Buddy Aid, andCombat

Lifesaver Skills

First ResponderCapability: RequiringResuscitation,Stabilization, and

Emergency Care

Forward Resuscitative andTheater HospitalizationCapabilities: Advanced

Emergency, Surgical, andAncillary Services

RSI is measured as aweapons likelihood tocause injury resulting inHCC1 or HCC 2

RSI is considered for both counter-personnel and counter-materialtechnologies

RSI is relevant to allNLW research andtechnology developmentefforts



8/12

Fielded Non-Lethal Weapons

TASER X26TM

Optical Distractors

FN303

Pen Flares

Permanent Paint

Washable Paint Training

Vehicle Lightweight

Arresting Device

M2 Net

12 Gauge / 40 MM

Point , Area and

Warning

Munitions

Modular Crowd

Control Munitions

Stingball Grenades &

Launch CupsAcoust ic Hail ing

Devices

Flash Bang Grenades

66mm Vehicle

Launched NL

Grenades

Portable Vehicle

Arresting Barrier



9/12

Joint Non-Lethal Weapons Program:

Capability Focus Areas

Counter Personnel :

Deny areas to individuals Move individuals Disable combatants Suppress combatants

Counter Material :

Stop/disable vehicles Stop/disable vessels Stop/disable/divert aircraft Deny access to a facility



10/12

Vehicle/Vessel Stopping

Independent Technical Reviews

Human Effects and Effectiveness Human Electromuscular Incapacitation

Nanosecond Electrical Pulse

Blunt Impact Technologies

New/Advanced Non-Lethal Materials

Joint Non-Lethal Weapons Program:

Technical Focus Areas

10

Non-Lethal Directed Energy Active Denial Technology

Laser Technology

Radio Frequency / High Power

Microwaves (Counter-Electronics)

Distribution A: Approved for public release; distribution unlimited


11/12

Non-Lethal Weapons Research and

Technology Development Goals

Provide warfighters with additional escalation-of-forceoptions while minimizing casualties and collateral damage

Stimulate innovative solutions to the toughest non-lethaltechnology challenges

Conduct the scientific research necessary to understandthe risk of injury and build confidence in the effectivenessof emerging technology solutions

Accelerate technology development to support the currentfight and conduct science and technology research to helpaddress uncertain future needs



12/12

Questions?

http://jnlwp.defense.gov

[email protected]

[email protected]


0000 00 00 jointnon-lethal weapons tech

Documents